Inhibition of Dot1L Alleviates Fulminant Hepatitis Through Myeloid-Derived Suppressor CellsSummary
Background & Aims: Fulminant hepatitis (FH) is a clinical syndrome characterized by sudden and severe liver dysfunction. Dot1L, a histone methyltransferase, is implicated in various physiologic and pathologic processes, including transcription regulation and leukemia. However, the role of Do...
Main Authors: | Wanlin Yang, Hongshuang Yu, Jiefang Huang, Xiang Miao, Qiwei Wang, Yanan Wang, Yiji Cheng, Shan He, Fang Zhao, Lijun Meng, Bei Wang, Fengtao Qian, Xiaohui Ren, Min Jin, Yuting Gu, Yanyun Zhang, Wei Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Cellular and Molecular Gastroenterology and Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X21000199 |
Similar Items
-
Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
by: Virginia López, et al.
Published: (2021-08-01) -
Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
by: Mei-Yan Dai, et al.
Published: (2023-06-01) -
Fulminant hepatitis E in an infant
by: Drishti Tolani, et al.
Published: (2017-01-01) -
Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
by: Khuloud Bajbouj, et al.
Published: (2021-10-01) -
Fulminant amebic colitis: A study of six cases
by: Nisheena R, et al.
Published: (2009-07-01)